Table. Summary of main blood and urine investigations performed in the patient with Plasmodium falciparum malaria, Tuscany, Italy, August 2018.
Parameters | Time after admission (Day 1) at the hospital in August 2018 | |||||
---|---|---|---|---|---|---|
Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | |
White blood cells (x10^9/L) (norm: 4.00–10.00) | 6.19 | 4.31 | 4.87 | 3.01 | 3.91 | 4.51 |
Haemoglobin (g/dL) (norm: 14–18) | 12.1 | 10.5 | 9.7 | 6.9 | 8.9 | 8.8 |
Haematocrit (%) (norm: 42.0–52.0) | 34.6 | 30 | 27.7 | 19.9 | 25.7 | 25.9 |
Platelet count (x10^9/L) (norm: 14–440) | 65 | 44 | 70 | 79 | 101 | 261 |
Prothrombin time (%)(norm: 70–130) | 62 | 61 | 69 | 70 | ND | ND |
INR (norm: 0.8–1.2) | 1.4 | 1.4 | 1.3 | 1.3 | ND | ND |
Partial thromboplastin time (sec) (norm: 22–38) | 27.1 | 27.5 | 27.7 | 27.1 | ND | ND |
Fibrinogen (mg/dL) (norm: 200–400) | 597 | 668 | 709 | 462 | ND | ND |
Glucose (mg/dL) (norm: 65–110) | 117 | 102 | 105 | ND | ND | 82 |
Creatinine (mg/dL) (norm: 0.44–0.9 ) | 0.92 | 0.93 | 0.97 | 0.91 | 0.77 | 0.69 |
Sodium (mEq/L) (norm: 135–145) | 135 | 133 | 134 | 136 | 139 | 139 |
Potassium (mEq/L) (norm: 3.5–5) | ND | 3.4 | 3.8 | 3.6 | 4 | 3.9 |
Alanine aminotransferase (U/L) (norm: 12–65) | 53 | 40 | ND | ND | 40 | 18 |
Total bilirubin (mg/dL) (norm: 0.2–1) | 3.2 | 3.1 | 4.2 | 2.0 | ND | ND |
LDH (U/L) (norm: 84–246) | ND | 640 | 866 | ND | 733 | ND |
Haptoglobin (g/L) (norm: 0.3–2.0) | ND | < 0.078 | ND | ND | ND | ND |
C-reactive protein (mg/L) (norm: <9) | 148 | ND | ND | ND | 88 | ND |
Procalcitonin (ng/mL) (norm: <0.5) | ND | ND | 5.09 | ND | 1.20 | ND |
Reticulocyte count (%) (norm: 0.5–2.5) | ND | 4.8 | ND | ND | ND | ND |
HIV 1–2 Ag/Ag (norm: neg) | ND | ND | ND | Neg | ND | ND |
Urine screening test for drugsa (norm: neg) | ND | ND | ND | Neg | ND | ND |
Ag: antigen; HIV: human immunodeficiency virus; INR: international normalised ratio; LDH: lactate dehydrogenase; ND: not done; Neg: negative.
a Including amfetamine, benzodiazepine, cocaine, ecstasy, marijuana, methadone, opiates.